One prick, three diseases: new rapid test could revolutionize screening

NCT ID NCT06082336

Recruiting now Diagnosis Sponsor: MagIA Diagnostics Source: ClinicalTrials.gov ↗

First seen Feb 03, 2026 · Last updated May 22, 2026 · Updated 19 times

Summary

This study evaluates a new point-of-care device called MaGIA IBC that can screen for HIV, hepatitis B, and hepatitis C from a single blood sample (from a finger prick or vein). About 252 adults with known or suspected infections will participate to see how accurate the device is compared to standard lab tests. The goal is to provide fast, reliable results in one visit, making screening easier and more accessible.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMBINED POINT OF CARE DIAGNOSTIC OF HIV, HBV AND HCV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Centre Hospitalier de Perpignan - Equipe Mobile Hépatites
RECRUITING

Perpignan, 66000, France

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
Hopital Européen de Marseille
COMPLETED

Marseille, France, 13003, France

Conditions

Explore the condition pages connected to this study.

COMBINED POINT OF CARE DIAGNOSTIC OF HIV, HBV AND HCV